← Back to Search

Active Rehabilitation Program (ARP) for Shoulder Injuries

N/A

Waitlist Available

Led By Justin L Staker, PhD, PT

Research Sponsored by University of Minnesota

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up within four weeks of treatment initiation and within four weeks of treatment termination

Awards & highlights

Study Summary

This trial will compare the effectiveness of two different approaches to treating shoulder instability in collegiate swimmers.

Eligible Conditions

Shoulder Injuries
Shoulder Pain

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ within four weeks of treatment initiation and within four weeks of treatment termination

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~within four weeks of treatment initiation and within four weeks of treatment termination

This trial's timeline: 3 weeks for screening, Varies for treatment, and within four weeks of treatment initiation and within four weeks of treatment termination for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in Western Ontario Instability Index (WOSI)

Change in the magnitude of 3D scapular rotations

Change in the magnitude of humeral head translations relative to the scapular glenoid

+1 more

Trial Design

2Treatment groups

Experimental Treatment

Group I: Nonspecific Passive Intervention (NPI)Experimental Treatment1 Intervention

Participants will be treated for symptomatic shoulder instability with the non-specific, generalized treatment intervention. For eight weeks, there will be two treatment sessions per week lasting 30-45 minutes. The NPI consists of a general approach to treating shoulder pain with passive modalities for pain modulation. These interventions are commonly practiced but have little evidence to support their use in the treatment of symptomatic shoulder instability. Although the components of the NPI will be pre-determined, the parameters and volumes of the components will be determined and documented by a study clinician over the treatment phase.

Group II: Active Rehabilitation Program (ARP)Experimental Treatment1 Intervention

Participants will be treated for symptomatic shoulder instability with the evidence-based, targeted treatment intervention. For eight weeks, there will be two treatment sessions per week lasting 30-45 minutes. Exercises in the ARP include: Low-load and high-duration rotator cuff strengthening exercises, progressive scapular muscle endurance training, plyometric strengthening exercises, and surface electromyographic (EMG) biofeedback. Each prescribed exercise in the ARP will be increased to match the participant's function at the discretion of the study clinician. Although the components of the ARP will be pre-determined, the parameters and volumes of the components will be determined and documented over the treatment phase.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Active Rehabilitation Program (ARP)

2021

N/A

~30

Nonspecific Passive Intervention (NPI)

2021

N/A

~30

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of MinnesotaLead Sponsor

1,377 Previous Clinical Trials

1,588,272 Total Patients Enrolled

1 Trials studying Shoulder Injuries

150 Patients Enrolled for Shoulder Injuries

Justin L Staker, PhD, PTPrincipal InvestigatorUniversity of Minnesota Medical School Department of Rehabilitation Medicine

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are individuals being recruited for this clinical investigation?

"The trial details, which were initially posted on September 1st 2021, present on clinicaltrials.gov suggest that this study is actively seeking participants. The information was last updated at the end of September 2022."

Answered by AI

How many participants are allowed to join this clinical trial?

"Affirmative. According to clinicaltrials.gov, this trial was originally advertised on September 1st 2021 and has since been updated on the 29th of September 2022. The investigators are in need of 50 study participants from a single centre."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Mitigating the Impact of Shoulder Movement Dysfunction; a Randomized Controlled Trial

2021. "Mitigating the Impact of Shoulder Movement Dysfunction; a Randomized Controlled Trial". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04852640.